FDA Approves Arcutis’ Zoryve® (Roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to 6 Years of Age
FDA批准Arcutis的Zoryve® (Roflumilast)霜0.15%用於治療兒童至6歲及成人的特應性皮炎
FDA Approves Arcutis’ Zoryve® (Roflumilast) Cream 0.15% for the Treatment of Atopic Dermatitis in Adults and Children Down to 6 Years of Age
FDA批准Arcutis的Zoryve® (Roflumilast)霜0.15%用於治療兒童至6歲及成人的特應性皮炎
譯文內容由第三人軟體翻譯。